Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety and clinical outcomes of Idursulfase in Hunter Syndrome
NCT00630747Phase 3Completed
- Sponsor
- Takeda
- Start
- Sep 2004
- Primary completion
- Jan 2008
- Modality
- Replacement Enzymes
- Countries
- 10
01
Overview
A Phase 3 trial of idursulfase in mucopolysaccharidosis type II, sponsored by Takeda. Started Sep 2004; status: completed.
02
Drugs
idursulfase
03
Conditions
mucopolysaccharidosis type II
Beyond the preview
Go deeper on NCT00630747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00630747.